Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 4/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.50 |
| ▸ | DPP3 | Q9NY33 | 4/20 | 0.49 |
| ▸ | GNRHR | P30968 | 1/20 | 0.48 |
| ▸ | BCHE | P06276 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 3/20 | 0.48 |
| ▸ | CTSS | P25774 | 3/20 | 0.48 |
| ▸ | CTSK | P43235 | 3/20 | 0.48 |
| ▸ | CTSH | P09668 | 1/20 | 0.48 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.47 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.47 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.46 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29942444 | 0.95 | KISS1R (0.56) | CXCR4KISS1RGNRHRABCC2NTSR2 | |
| SCHEMBL11593491 | 0.95 | KISS1R (0.56) | CXCR4KISS1RGNRHRABCC2NTSR2 | |
| Hydrochloric Acid SCHEMBL11592749 | 0.95 | KISS1R (0.55) | CXCR4KISS1RGNRHRABCC2NTSR2 | |
| SCHEMBL29833824 | 0.93 | CXCR4 (0.52) | CXCR4KISS1RDPP3CTSLCTSS | |
| SCHEMBL30597309 | 0.92 | DPP3 (0.57) | CXCR4KISS1RDPP3CTSLCTSS | |
| SCHEMBL1307858 | 0.90 | KISS1R (0.58) | CXCR4KISS1RGNRHRNTSR2NTSR1 | |
| SCHEMBL30567818 | 0.90 | KISS1R (0.58) | CXCR4KISS1RGNRHRNTSR2NTSR1 | |
| SCHEMBL31005883 | 0.89 | KISS1R (0.57) | CXCR4KISS1RDPP3CTSLCTSS | |
| Hydrochloric Acid SCHEMBL11644315 | 0.89 | KISS1R (0.57) | CXCR4KISS1RGNRHRNTSR2NTSR1 | |
| SCHEMBL31147129 | 0.89 | CXCR4 (0.58) | CXCR4KISS1RDPP3CTSLCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240033320-A1 | IMMUNORHELIN COMPOUNDS FOR INTRACELLULAR INFECTIONS | ISR Immune System Regulation Holding AB (publ) (SE) | 2024-02-01 | — | — | US | claimed |
| US-11564969-B2 | Immunorhelin compounds for intracellular infections | ISR Immune System Regulation Holding AB (publ) (SE) | 2023-01-31 | — | — | US | claimed |
| US-11434258-B2 | Compounds (immunorhelins) | ISR Immune System Regulation Holding AB (SE) | 2022-09-06 | — | — | US | claimed |
| US-20240033320-A1 | IMMUNORHELIN COMPOUNDS FOR INTRACELLULAR INFECTIONS | ISR Immune System Regulation Holding AB (publ) (SE) | 2024-02-01 | — | — | US | disclosed |
| US-20230118205-A1 | NOVEL COMPOUNDS (IMMUNORHELINS) | ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL (SE) | 2023-04-20 | — | — | US | disclosed |
| US-11564969-B2 | Immunorhelin compounds for intracellular infections | ISR Immune System Regulation Holding AB (publ) (SE) | 2023-01-31 | — | — | US | disclosed |
| US-11434258-B2 | Compounds (immunorhelins) | ISR Immune System Regulation Holding AB (SE) | 2022-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230118205-A1 | NOVEL COMPOUNDS (IMMUNORHELINS) | GNRHR, FSHR, LHCGR | CXCR4 281/4885KISS1R 20/4885DPP3 616/4885 |
| US-20240033320-A1 | IMMUNORHELIN COMPOUNDS FOR INTRACELLULAR INFECTIONS | GNRHR, GHRHR, FSHR | CXCR4 633/4885KISS1R 40/4885DPP3 1366/4885 |
| US-11564969-B2 | Immunorhelin compounds for intracellular infections | GNRHR, GHRHR, FSHR | CXCR4 633/4885KISS1R 40/4885DPP3 1366/4885 |
| US-11434258-B2 | Compounds (immunorhelins) | GNRHR, FSHR, LHCGR | CXCR4 291/4885KISS1R 19/4885DPP3 685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.